Dogs to explain human retinal disease?

Article

A genetic mutation that is associated with recessive cone-rod dystrophy in dachshunds may play the same role in humans, according to a study in the August 2008 issue of Genome Research.

A genetic mutation that is associated with recessive cone-rod dystrophy in dachshunds may play the same role in humans, according to a study in the August 2008 issue of Genome Research.

Dr Frode Lingaas of the Department of Basic Sciences and Aquatic Medicine at the Norwegian School of Veterinary Science, Oslo, Norway, and colleagues performed genome-wide association-based Sibling Transmission Disequilibrium Test (sibTDT) analysis to identify and then resequence an area on canine chromosome 5, which contains more than 70 genes.

The analysis showed that, in dachshunds suffering from cone-rod dystrophy, one gene - nephronophthisis/nephroretinin 4 (NPHP4) - had an area missing, which produced a truncated protein that interferes with interaction in the eye but not the kidney (NPHP4's other biological target).

The team concluded that this mutation, the truncated protein produced by NPHP4, is responsible for the development of cone-rod dystrophy in a canine model. As other NPHP4 mutations have been associated with eye and kidney disease in humans, the team speculate that further investigation of this mutation could result in an explanation for similar degenerative retinal diseases in humans.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.